based on emerging data from the laboratory, clinical trials, and data on circulating 25-hydroxyvitamin d amassed during many decades, it is likely that for the optimal functioning of these systems, significant vitamin d should be available on a daily basis to ensure stable circulating concentrations, implying that variation in vitamin d dosing schedules could have profound effects on the outcomes of clinical trials because of the short circulating half-life of intact vitamin d.